Stock Events

Stock Events

Aclaris Therapeutics (8AT.F) Q3 2024 Earnings

7AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.27

-0.22

-0.18

-0.14

Details

Expected EPS

-0.187396709

Actual EPS

-0.13732049999999998

Surprise EPS

0.05

Surprise Percent

+26.72%

Description

Aclaris Therapeutics (8AT.F) has reported earnings of -0.13732049999999998 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.